CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (151,867)	$ (39,649)
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	133,530	141,645
Amortization of deferred financing costs	3,753	3,251
Amortization of debt discount/(premium), net	(2,540)	(774)
Amortization of stock compensation costs	13,068	8,305
Straight-line rent income	(5,745)	(6,612)
Amortization of acquired above (below) market leases, net	(706)	(993)
Ground rent expense	589	601
Net gain on real estate venture transactions	(54,503)	(181)
Total gain on sale of real estate	0	(781)
Gain on early extinguishment of debt	(941)	0
Provision for impairment	44,407	16,134
Loss from unconsolidated real estate ventures, including income distributions	153,957	24,504
Income tax provision	11	35
Changes in assets and liabilities:
Accounts receivable	1,787	(2,362)
Other assets	(14,343)	(24,619)
Accounts payable and accrued expenses	4,851	(8,992)
Deferred income, gains and rent	(1,740)	(1,196)
Other liabilities	634	3,089
Net cash provided by operating activities	124,202	111,405
Cash flows from investing activities:
Proceeds from the sale of properties	45,250	51,285
Capital expenditures for tenant improvements	(55,214)	(34,219)
Capital expenditures for redevelopments	(8,747)	(42,592)
Capital expenditures for developments	(29,580)	(30,149)
Advances for the purchase of tenant assets, net of repayments	1,377	(9,292)
Investment in unconsolidated real estate ventures	(143,751)	(72,715)
Deposits for real estate	0	3,500
Capital distributions from unconsolidated real estate ventures	3,941	2,700
Leasing costs paid	(6,307)	(7,969)
Net cash used in investing activities	(193,031)	(139,451)
Cash flows from financing activities:
Proceeds from credit facility borrowings	131,000	172,000
Repayments of credit facility borrowings	(91,000)	(260,500)
Proceeds from unsecured notes	400,000	0
Repayments of unsecured notes	(339,059)	(54,301)
Proceeds from unsecured term loan	13,000	70,000
Proceeds from secured term loan	0	245,000
Proceeds from construction loan	15,943	0
Debt financing costs paid	(6,334)	(4,371)
Shares used for employee taxes upon vesting of share awards	(1,028)	(952)
Distributions paid to shareholders	(78,303)	(98,306)
Distributions to noncontrolling interest	(231)	(294)
Net cash provided by financing activities	43,988	68,276
Increase/(Decrease) in cash and cash equivalents and restricted cash	(24,841)	40,230
Cash and cash equivalents and restricted cash at beginning of period	67,534	18,387
Cash and cash equivalents and restricted cash at end of period	42,693	58,617
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents, beginning of period	58,319	17,551
Restricted cash, beginning of period	9,215	836
Cash and cash equivalents and restricted cash at beginning of period	67,534	18,387
Cash and cash equivalents, end of period	36,498	47,872
Restricted cash, end of period	6,195	10,745
Cash and cash equivalents and restricted cash at end of period	42,693	58,617
Supplemental disclosure:
Cash paid for interest, net of capitalized interest during the nine months ended September 30, 2024 and 2023 of $13,866 and $12,602, respectively	86,398	73,217
Cash paid for income taxes	0	550
Supplemental disclosure of non-cash activity:
Dividends and distributions declared but not paid	26,230	26,027
Change in investment in real estate ventures as a result of deconsolidation	0	8,595
Change in operating real estate from deconsolidation of operating properties	0	(7,814)
Change in notes receivable from sale of properties	19,919	0
Change in capital expenditures financed through accounts payable at period end	8,383	4,276
Change in capital expenditures financed through retention payable at period end	$ (2,331)	$ 2,587